Philina Lee is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as a Board Member for DBV Technologies since October 2025. Prior to this role, Philina held various leadership positions at Blueprint Medicines from August 2014 to October 2025, including Chief Commercial Officer and Senior Vice President, Head of Portfolio Strategy, where market development and new product commercialization for investigational medicines were primary responsibilities. Additional experience includes serving as a Board Member at Fusion Pharmaceuticals and leading US marketing and commercial operations for Algeta ASA. At Sanofi, Philina developed global brand strategies for oncology products and achieved significant recognition for marketing efforts. Philina's career began in healthcare strategy consulting and academic research, with advanced degrees from the Massachusetts Institute of Technology and the University of Alberta.
This person is not in the org chart
This person is not in any teams
This person is not in any offices